new version V2017

insulin therapy

     

TrialStudied treatmentControl treatmentpatientsROBResultNCT

diabetes type 2

glargine
Rosenstock glargineSuggesting
Eliaschewitz glargineSuggesting
Massi glargineSuggesting
Yki-Yarvinen glargineNegative
Fonseca glargineNegative
Pan glargine -
Philis-Tsimikas glargineSuggesting
Wang glargineSuggesting
Yki-Yarvinen glargineSuggesting
YokoyamaglargineNegative
Fritche morning insulin glarginebedtime insulin glargineSuggesting
Riddle glargineNPH + SUNegative
HOE 901/3002, 2000glargineNPH -
Riddle POC 4002 Glargine, 2003glargineNPH -
Herman, 2005lispro +glarginecontinuous infusion -
OPAL, 2008glulisine + glargineglulisine + glargine -
Owens, 2011insulin glulisine + glargineglargine once dailyNegative
lixisenatide
GETGOAL-Llixisenatideglargine once daily - NCT00715624